Public recall detail

Taro-Docusate Capsules USP 100 mg (2014-04-25)

medium
Recall Safety notice
Quick summary

Quick summary: Taro-Docusate Capsules USP 100 mg (2014-04-25) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Taro-Docusate Capsules USP 100 mg (2014-04-25) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionTaro-Docusate Capsules USP 100 mg DIN, NPN, DIN-HIM DIN 00716731 Dosage form Capsule Strength 100 mg Lot or serial number 230000505 230000506 230000507 230000508 230000509 230000510 230000491 230000428 230000516 Companies Recalling Firm Taro Pharmaceuticals Inc. 130 East Drive Brampton L6T 1C1 Ontario CANADA Marketing Authorization Holder Taro Pharmaceuticals Inc. 130 East Drive Brampton L6T 1C1 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...